Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0002697,GO:0002697,regulation of immune effector process,11/39,353/18800,9.17464680904001e-11,1.61932516179556e-07,8.79800341372153e-08,BST2/CD74/CD80/CEACAM1/HAVCR2/IL18R1/IL4R/LGALS9/NECTIN2/TNFRSF4/VSIG4,11
GO:0002286,GO:0002286,T cell activation involved in immune response,7/39,116/18800,3.7047971508479604e-09,3.26948348562333e-06,1.77635273916973e-06,CD74/CD80/CEACAM1/HAVCR2/IL18R1/IL4R/LGALS9,7
GO:0050868,GO:0050868,negative regulation of T cell activation,7/39,125/18800,6.2511319409541e-09,3.67774929192799e-06,1.99816884147691e-06,CD74/CD80/CEACAM1/HAVCR2/IL4R/LGALS9/VSIG4,7
GO:1903038,GO:1903038,negative regulation of leukocyte cell-cell adhesion,7/39,144/18800,1.6739283263288e-08,6.3625620325715e-06,3.45686238954682e-06,CD74/CD80/CEACAM1/HAVCR2/IL4R/LGALS9/VSIG4,7
GO:0046718,GO:0046718,viral entry into host cell,7/39,146/18800,1.84189397920961e-08,6.3625620325715e-06,3.45686238954682e-06,ANPEP/CD74/CD80/CXADR/LGALS9/NECTIN2/TNFRSF4,7
GO:0022407,GO:0022407,regulation of cell-cell adhesion,10/39,456/18800,2.16291060597332e-08,6.3625620325715e-06,3.45686238954682e-06,CD27/CD74/CD80/CEACAM1/FSTL3/HAVCR2/IL4R/LGALS9/PLAUR/VSIG4,10
GO:0070665,GO:0070665,positive regulation of leukocyte proliferation,7/39,158/18800,3.18040252530099e-08,7.01676307144531e-06,3.81229829019632e-06,BST2/CD74/CD80/CSF1/HAVCR2/LGALS9/TNFRSF4,7
GO:0051250,GO:0051250,negative regulation of lymphocyte activation,7/39,161/18800,3.62092806895357e-08,7.10104226855895e-06,3.85808826996106e-06,CD74/CD80/CEACAM1/HAVCR2/IL4R/LGALS9/VSIG4,7
GO:0007159,GO:0007159,leukocyte cell-cell adhesion,9/39,381/18800,6.49838461256587e-08,1.02157920310805e-05,5.55037217254469e-06,CD27/CD74/CD80/CEACAM1/HAVCR2/IL4R/LGALS9/NT5E/VSIG4,9
GO:1902105,GO:1902105,regulation of leukocyte differentiation,8/39,283/18800,9.8041481500279e-08,1.23095103283099e-05,6.68791645092609e-06,CD27/CD74/CD80/CEACAM1/CSF1/FSTL3/IL4R/LGALS9,8
GO:0002443,GO:0002443,leukocyte mediated immunity,9/39,457/18800,3.03765199380188e-07,2.14458230762413e-05,1.16517935425411e-05,BST2/CD27/CD74/CEACAM1/HAVCR2/IL18R1/IL4R/LGALS9/NECTIN2,9
GO:0070661,GO:0070661,leukocyte proliferation,8/39,330/18800,3.17133366640025e-07,2.15284766199863e-05,1.16967002837677e-05,BST2/CD74/CD80/CSF1/HAVCR2/LGALS9/TNFRSF4/VSIG4,8
GO:0002825,GO:0002825,regulation of T-helper 1 type immune response,4/39,29/18800,3.61708752297848e-07,2.36450351039149e-05,1.28466539315142e-05,CD80/HAVCR2/IL18R1/IL4R,4
GO:0050863,GO:0050863,regulation of T cell activation,8/39,342/18800,4.1584574637732e-07,2.47376679132004e-05,1.34402954936189e-05,CD27/CD74/CD80/CEACAM1/HAVCR2/IL4R/LGALS9/VSIG4,8
GO:0002274,GO:0002274,myeloid leukocyte activation,7/39,232/18800,4.37544157763259e-07,2.47376679132004e-05,1.34402954936189e-05,CD74/CSF1/HAVCR2/IL4R/LGALS9/NECTIN2/VSIG4,7
GO:0002858,GO:0002858,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,3/39,8/18800,4.58894340822539e-07,2.47376679132004e-05,1.34402954936189e-05,CEACAM1/HAVCR2/NECTIN2,3
GO:0002420,GO:0002420,natural killer cell mediated cytotoxicity directed against tumor cell target,3/39,9/18800,6.87353042123842e-07,3.19257399828574e-05,1.7345668182128e-05,CEACAM1/HAVCR2/NECTIN2,3
GO:0002460,GO:0002460,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,8/39,370/18800,7.53432308756045e-07,3.3650631120306e-05,1.82828238858499e-05,CD27/CD74/CD80/CEACAM1/HAVCR2/IL18R1/IL4R/NECTIN2,8
GO:0002696,GO:0002696,positive regulation of leukocyte activation,8/39,421/18800,1.98088037009534e-06,7.13521194534342e-05,3.87665309808132e-05,CD27/CD74/CD80/HAVCR2/IL4R/LGALS9/NECTIN2/TNFRSF4,8
GO:1901741,GO:1901741,positive regulation of myoblast fusion,3/39,16/18800,4.53649907090896e-06,0.0001334486810025,7.25043974315449e-05,CXCL9/GDF15/IL4R,3
GO:0019221,GO:0019221,cytokine-mediated signaling pathway,8/39,486/18800,5.72334609126939e-06,0.0001656017352637,8.99735684063229e-05,CD74/CEACAM1/CSF1/CXCL9/IL18R1/IL4R/TNFRSF1A/TNFRSF4,8
GO:0050870,GO:0050870,positive regulation of T cell activation,6/39,223/18800,6.1259940816408e-06,0.0001743932186144,9.47500952185868e-05,CD27/CD74/CD80/HAVCR2/IL4R/LGALS9,6
GO:0050670,GO:0050670,regulation of lymphocyte proliferation,6/39,230/18800,7.31181895675893e-06,0.0002048469914076,0.0001112960245548,CD74/CD80/HAVCR2/LGALS9/TNFRSF4/VSIG4,6
GO:0002837,GO:0002837,regulation of immune response to tumor cell,3/39,20/18800,9.18211061509325e-06,0.0002418869438155,0.0001314203106103,CEACAM1/HAVCR2/NECTIN2,3
GO:0045063,GO:0045063,T-helper 1 cell differentiation,3/39,21/18800,1.06970890656818e-05,0.0002595843179334,0.0001410355232666,CD80/IL18R1/IL4R,3
GO:1901224,GO:1901224,positive regulation of NIK/NF-kappaB signaling,4/39,67/18800,1.10304950963216e-05,0.0002595843179334,0.0001410355232666,CD27/HAVCR2/IL18R1/LGALS9,4
GO:0002834,GO:0002834,regulation of response to tumor cell,3/39,22/18800,1.23683289531456e-05,0.0002763303873709,0.0001501338797643,CEACAM1/HAVCR2/NECTIN2,3
GO:0002519,GO:0002519,natural killer cell tolerance induction,2/39,3/18800,1.25633832240503e-05,0.0002771796423806,0.0001505952910146,HAVCR2/LGALS9,2
GO:0032722,GO:0032722,positive regulation of chemokine production,4/39,70/18800,1.3136322340216e-05,0.0002862420855614,0.0001555190338133,CD74/HAVCR2/IL4R/LGALS9,4
GO:0031348,GO:0031348,negative regulation of defense response,6/39,268/18800,1.74423500824067e-05,0.0003498380442664,0.0001900715421659,CEACAM1/HAVCR2/LGALS9/NT5E/TNFRSF1A/VSIG4,6
GO:0001911,GO:0001911,negative regulation of leukocyte mediated cytotoxicity,3/39,25/18800,1.83927790186983e-05,0.0003607028329778,0.0001959745226436,CEACAM1/HAVCR2/LGALS9,3
GO:0002418,GO:0002418,immune response to tumor cell,3/39,27/18800,2.33237492691266e-05,0.0004457895232489,0.0002422032239032,CEACAM1/HAVCR2/NECTIN2,3
GO:0002700,GO:0002700,regulation of production of molecular mediator of immune response,5/39,167/18800,2.34891930097181e-05,0.0004457895232489,0.0002422032239032,BST2/CD74/IL18R1/IL4R/TNFRSF4,5
GO:0051048,GO:0051048,negative regulation of secretion,5/39,167/18800,2.34891930097181e-05,0.0004457895232489,0.0002422032239032,CD74/CEACAM1/INHBB/LGALS9/TNFRSF1A,5
GO:0031342,GO:0031342,negative regulation of cell killing,3/39,28/18800,2.6085125234861e-05,0.0004746417117477,0.0002578789917412,CEACAM1/HAVCR2/LGALS9,3
GO:0046651,GO:0046651,lymphocyte proliferation,6/39,296/18800,3.05135888537331e-05,0.00052287848861,0.0002840866575958,CD74/CD80/HAVCR2/LGALS9/TNFRSF4/VSIG4,6
GO:0034109,GO:0034109,homotypic cell-cell adhesion,4/39,93/18800,4.0422975482059e-05,0.0006545555204204,0.0003556284950666,CEACAM1/CXADR/DSC2/PLAUR,4
GO:0032602,GO:0032602,chemokine production,4/39,98/18800,4.96403350796617e-05,0.0007822784947821,0.0004250220418944,CD74/HAVCR2/IL4R/LGALS9,4
GO:0035710,GO:0035710,"CD4-positive, alpha-beta T cell activation",4/39,102/18800,5.8051547572146e-05,0.0008909650562159,0.0004840728589311,CD80/IL18R1/IL4R/LGALS9,4
GO:0002347,GO:0002347,response to tumor cell,3/39,42/18800,8.95913457335486e-05,0.0012549898826961,0.0006818522636864,CEACAM1/HAVCR2/NECTIN2,3
GO:0001818,GO:0001818,negative regulation of cytokine production,6/39,363/18800,9.46847728298304e-05,0.0013158946775169,0.0007149426278323,BST2/CEACAM1/HAVCR2/INHBB/LGALS9/VSIG4,6
GO:0046596,GO:0046596,regulation of viral entry into host cell,3/39,43/18800,9.61726487704273e-05,0.0013261306646859,0.000720503972285,CD74/LGALS9/NECTIN2,3
GO:0018108,GO:0018108,peptidyl-tyrosine phosphorylation,6/39,373/18800,0.0001099025785049,0.0014523715789793,0.0007890922966752,CD74/CD80/FGFR2/GFRA1/SPINK1/TNFRSF1A,6
GO:0030595,GO:0030595,leukocyte chemotaxis,5/39,236/18800,0.0001214381653235,0.001576017366148,0.0008562706548745,CD74/CSF1/CXADR/CXCL9/LGALS9,5
GO:0043300,GO:0043300,regulation of leukocyte degranulation,3/39,49/18800,0.000142346959215,0.001807499158378,0.0009820377118129,CEACAM1/IL4R/LGALS9,3
GO:0001909,GO:0001909,leukocyte mediated cytotoxicity,4/39,131/18800,0.0001532980803367,0.001892105676884,0.0010280055295311,CEACAM1/HAVCR2/LGALS9/NECTIN2,4
GO:0035860,GO:0035860,glial cell-derived neurotrophic factor receptor signaling pathway,2/39,10/18800,0.0001867274123393,0.0022268505593167,0.0012098767613165,GDF15/GFRA1,2
GO:0070228,GO:0070228,regulation of lymphocyte apoptotic process,3/39,57/18800,0.0002234899127733,0.0025285877951601,0.0013738145110427,CD27/CD74/LGALS9,3
GO:0032102,GO:0032102,negative regulation of response to external stimulus,6/39,429/18800,0.0002349564328087,0.0026081641755185,0.0014170493895318,CEACAM1/HAVCR2/LGALS9/NT5E/TNFRSF1A/VSIG4,6
GO:0140253,GO:0140253,cell-cell fusion,3/39,59/18800,0.0002475953003165,0.0026975660806089,0.0014656226029132,CXCL9/GDF15/IL4R,3
GO:0044650,GO:0044650,adhesion of symbiont to host cell,2/39,12/18800,0.0002731493692039,0.0029577216972082,0.0016069685201471,INHBB/NECTIN2,2
GO:0032103,GO:0032103,positive regulation of response to external stimulus,6/39,442/18800,0.0002758538948047,0.0029687934410387,0.0016129839420225,CD74/CSF1/HAVCR2/LGALS9/NECTIN2/TNFRSF1A,6
GO:0097530,GO:0097530,granulocyte migration,4/39,154/18800,0.0002849081931876,0.0030476543089469,0.0016558300733267,CD74/CSF1/CXADR/CXCL9,4
GO:0071375,GO:0071375,cellular response to peptide hormone stimulus,5/39,294/18800,0.0003366702818356,0.0034150749852872,0.0018554544873098,BAIAP2/CEACAM1/GDF15/INHBB/SPINK1,5
GO:0070372,GO:0070372,regulation of ERK1 and ERK2 cascade,5/39,311/18800,0.000435460912767,0.0042230137968888,0.002294418111803,CD74/CEACAM1/FGFR2/HAVCR2/LGALS9,5
GO:0002440,GO:0002440,production of molecular mediator of immune response,5/39,312/18800,0.0004418860921742,0.0042619068452874,0.0023155492089201,BST2/CD74/IL18R1/IL4R/TNFRSF4,5
GO:0070227,GO:0070227,lymphocyte apoptotic process,3/39,75/18800,0.0005026317207882,0.0047440908405949,0.0025775260210419,CD27/CD74/LGALS9,3
GO:0043299,GO:0043299,leukocyte degranulation,3/39,76/18800,0.0005225391476546,0.0049057531681409,0.0026653592581937,CEACAM1/IL4R/LGALS9,3
GO:0002830,GO:0002830,positive regulation of type 2 immune response,2/39,17/18800,0.0005591755545247,0.0051672505431215,0.0028074341701408,CD74/IL4R,2
GO:2001267,GO:2001267,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,2/39,17/18800,0.0005591755545247,0.0051672505431215,0.0028074341701408,LGALS9/PLAUR,2
GO:0001906,GO:0001906,cell killing,4/39,185/18800,0.000570402094723,0.0052435400895109,0.0028488832691483,CEACAM1/HAVCR2/LGALS9/NECTIN2,4
GO:0032496,GO:0032496,response to lipopolysaccharide,5/39,333/18800,0.0005941401134497,0.0054334575141907,0.0029520678666633,CD80/CXCL9/FGFR2/HAVCR2/LGALS9,5
GO:0002709,GO:0002709,regulation of T cell mediated immunity,3/39,88/18800,0.0008017775572853,0.0070756869430435,0.0038443123930894,CEACAM1/IL18R1/NECTIN2,3
GO:0002690,GO:0002690,positive regulation of leukocyte chemotaxis,3/39,94/18800,0.0009710122588389,0.0082395992156287,0.0044766810111452,CD74/CSF1/LGALS9,3
GO:0016064,GO:0016064,immunoglobulin mediated immune response,4/39,216/18800,0.0010171057697958,0.0085894338932524,0.0046667507241705,CD27/CD74/IL4R/NECTIN2,4
GO:0030728,GO:0030728,ovulation,2/39,23/18800,0.0010320856835746,0.0086744344357579,0.0047129326202328,IL4R/INHBB,2
GO:0002367,GO:0002367,cytokine production involved in immune response,3/39,100/18800,0.0011613448925537,0.0095275875349254,0.0051764617529847,BST2/CD74/IL18R1,3
GO:0042692,GO:0042692,muscle cell differentiation,5/39,387/18800,0.0011659823838775,0.0095275875349254,0.0051764617529847,CXADR/CXCL9/FGFR2/GDF15/IL4R,5
GO:0008630,GO:0008630,intrinsic apoptotic signaling pathway in response to DNA damage,3/39,101/18800,0.0011951863258645,0.0097212159684372,0.0052816625896802,CD74/SHISA5/TNFRSF1A,3
GO:0097305,GO:0097305,response to alcohol,4/39,235/18800,0.0013885598524177,0.0109411077657021,0.0059444456087995,CD27/FGFR2/INHBB/SPINK1,4
GO:0043434,GO:0043434,response to peptide hormone,5/39,404/18800,0.0014105493217382,0.0110649757905247,0.0060117447115956,BAIAP2/CEACAM1/GDF15/INHBB/SPINK1,5
GO:0098901,GO:0098901,regulation of cardiac muscle cell action potential,2/39,28/18800,0.0015319478306735,0.0118073708346674,0.0064150975580032,CXADR/DSC2,2
GO:0060603,GO:0060603,mammary gland duct morphogenesis,2/39,30/18800,0.0017583475233923,0.0133770835292563,0.0072679428031325,CSF1/FGFR2,2
GO:0010951,GO:0010951,negative regulation of endopeptidase activity,4/39,251/18800,0.001767648581508,0.0133901276667886,0.0072750298520616,BST2/CD27/PLAUR/SPINK1,4
GO:0043171,GO:0043171,peptide catabolic process,2/39,31/18800,0.0018771551037355,0.0137647976323816,0.0074785928988219,ANPEP/GGT1,2
GO:0043304,GO:0043304,regulation of mast cell degranulation,2/39,32/18800,0.0019996809201432,0.0137647976323816,0.0074785928988219,IL4R/LGALS9,2
GO:0006690,GO:0006690,icosanoid metabolic process,3/39,121/18800,0.002007161615366,0.0137647976323816,0.0074785928988219,CD74/GGT1/TNFRSF1A,3
GO:0035602,GO:0035602,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,FGFR2,1
GO:0035603,GO:0035603,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,FGFR2,1
GO:0035604,GO:0035604,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,FGFR2,1
GO:0035607,GO:0035607,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,FGFR2,1
GO:0046086,GO:0046086,adenosine biosynthetic process,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,NT5E,1
GO:0046449,GO:0046449,creatinine metabolic process,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,MME,1
GO:0046814,GO:0046814,coreceptor-mediated virion attachment to host cell,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,NECTIN2,1
GO:0060611,GO:0060611,mammary gland fat development,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,CSF1,1
GO:0061837,GO:0061837,neuropeptide processing,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,MME,1
GO:0070238,GO:0070238,activated T cell autonomous cell death,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,LGALS9,1
GO:0070241,GO:0070241,positive regulation of activated T cell autonomous cell death,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,LGALS9,1
GO:0086072,GO:0086072,AV node cell-bundle of His cell adhesion involved in cell communication,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,CXADR,1
GO:0099564,GO:0099564,"modification of synaptic structure, modulating synaptic transmission",1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,BAIAP2,1
GO:1990636,GO:1990636,reproductive senescence,1/39,1/18800,0.0020744680851068,0.0137647976323816,0.0074785928988219,INHBB,1
GO:0022612,GO:0022612,gland morphogenesis,3/39,123/18800,0.0021031916852464,0.0138971513473717,0.0075505023870318,CEACAM1/CSF1/FGFR2,3
GO:0033006,GO:0033006,regulation of mast cell activation involved in immune response,2/39,34/18800,0.0022558267660602,0.0145843745131734,0.0079238796370961,IL4R/LGALS9,2
GO:0098742,GO:0098742,cell-cell adhesion via plasma-membrane adhesion molecules,4/39,279/18800,0.002595040566301,0.0162998099627093,0.0088558979430613,CEACAM1/CXADR/DSC2/NECTIN2,4
GO:0042092,GO:0042092,type 2 immune response,2/39,37/18800,0.0026675553638797,0.0166368735591792,0.0090390289622258,CD74/IL4R,2
GO:0034341,GO:0034341,response to interferon-gamma,3/39,140/18800,0.003036089495717,0.0186714214632076,0.0101444251993333,BST2/CD74/LGALS9,3
GO:0050921,GO:0050921,positive regulation of chemotaxis,3/39,140/18800,0.003036089495717,0.0186714214632076,0.0101444251993333,CD74/CSF1/LGALS9,3
GO:0002792,GO:0002792,negative regulation of peptide secretion,2/39,40/18800,0.0031119369899375,0.0189398923697921,0.0102902889213542,CD74/INHBB,2
GO:0050856,GO:0050856,regulation of T cell receptor signaling pathway,2/39,44/18800,0.0037545479004427,0.0222375068600048,0.0120819255997998,CEACAM1/NECTIN2,2
GO:0002415,GO:0002415,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,PIGR,1
GO:0006788,GO:0006788,heme oxidation,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,HMOX2,1
GO:0021847,GO:0021847,ventricular zone neuroblast division,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,FGFR2,1
GO:0030382,GO:0030382,sperm mitochondrion organization,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,NECTIN2,1
GO:0032605,GO:0032605,hepatocyte growth factor production,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,INHBB,1
GO:0042488,GO:0042488,positive regulation of odontogenesis of dentin-containing tooth,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,CSF1,1
GO:0046032,GO:0046032,ADP catabolic process,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,NT5E,1
GO:0060529,GO:0060529,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,FGFR2,1
GO:0060595,GO:0060595,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,FGFR2,1
GO:0060667,GO:0060667,branch elongation involved in salivary gland morphogenesis,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,FGFR2,1
GO:0060915,GO:0060915,mesenchymal cell differentiation involved in lung development,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,FGFR2,1
GO:1901253,GO:1901253,negative regulation of intracellular transport of viral material,1/39,2/18800,0.0041447428733761,0.0223032657667956,0.012117653265872,BST2,1
GO:0032924,GO:0032924,activin receptor signaling pathway,2/39,47/18800,0.0042735688985783,0.0228571185030021,0.0124185686335082,FSTL3/INHBB,2
GO:0045601,GO:0045601,regulation of endothelial cell differentiation,2/39,47/18800,0.0042735688985783,0.0228571185030021,0.0124185686335082,CEACAM1/TNFRSF1A,2
GO:0042304,GO:0042304,regulation of fatty acid biosynthetic process,2/39,49/18800,0.0046370136064346,0.0245775646106823,0.0133533092949644,CD74/CEACAM1,2
GO:0006692,GO:0006692,prostanoid metabolic process,2/39,50/18800,0.0048239218416311,0.0251156992639499,0.0136456848244869,CD74/TNFRSF1A,2
GO:0006693,GO:0006693,prostaglandin metabolic process,2/39,50/18800,0.0048239218416311,0.0251156992639499,0.0136456848244869,CD74/TNFRSF1A,2
GO:0043303,GO:0043303,mast cell degranulation,2/39,50/18800,0.0048239218416311,0.0251156992639499,0.0136456848244869,IL4R/LGALS9,2
GO:0042113,GO:0042113,B cell activation,4/39,336/18800,0.0050353524052909,0.0259107784120657,0.0140776616271906,BST2/CD27/CD74/TNFRSF4,4
GO:0002448,GO:0002448,mast cell mediated immunity,2/39,52/18800,0.005208038277768,0.0265670160701173,0.0144342040494271,IL4R/LGALS9,2
GO:0060759,GO:0060759,regulation of response to cytokine stimulus,3/39,178/18800,0.0059386413738607,0.0286249322195455,0.0155522965570335,CD74/CSF1/TNFRSF1A,3
GO:0002414,GO:0002414,immunoglobulin transcytosis in epithelial cells,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,PIGR,1
GO:0010751,GO:0010751,negative regulation of nitric oxide mediated signal transduction,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,SPINK1,1
GO:0021769,GO:0021769,orbitofrontal cortex development,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,FGFR2,1
GO:0038016,GO:0038016,insulin receptor internalization,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,CEACAM1,1
GO:0043317,GO:0043317,regulation of cytotoxic T cell degranulation,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,CEACAM1,1
GO:0043318,GO:0043318,negative regulation of cytotoxic T cell degranulation,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,CEACAM1,1
GO:0046882,GO:0046882,negative regulation of follicle-stimulating hormone secretion,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,INHBB,1
GO:0060400,GO:0060400,negative regulation of growth hormone receptor signaling pathway,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,GDF15,1
GO:0060523,GO:0060523,prostate epithelial cord elongation,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,FGFR2,1
GO:0090187,GO:0090187,positive regulation of pancreatic juice secretion,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,SPINK1,1
GO:1901143,GO:1901143,insulin catabolic process,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,CEACAM1,1
GO:1904017,GO:1904017,cellular response to Thyroglobulin triiodothyronine,1/39,3/18800,0.0062108326184522,0.0286249322195455,0.0155522965570335,INHBB,1
GO:0046456,GO:0046456,icosanoid biosynthetic process,2/39,57/18800,0.0062277472930909,0.0286249322195455,0.0155522965570335,CD74/GGT1,2
GO:0060135,GO:0060135,maternal process involved in female pregnancy,2/39,58/18800,0.0064417617414491,0.0293790942471778,0.0159620425580313,HAVCR2/LGALS9,2
GO:0086065,GO:0086065,cell communication involved in cardiac conduction,2/39,58/18800,0.0064417617414491,0.0293790942471778,0.0159620425580313,CXADR/DSC2,2
GO:0034113,GO:0034113,heterotypic cell-cell adhesion,2/39,61/18800,0.0071036975394729,0.0320544213954635,0.0174155824608721,CXADR/DSC2,2
GO:0051346,GO:0051346,negative regulation of hydrolase activity,4/39,371/18800,0.0071191689444882,0.0320544213954635,0.0174155824608721,BST2/CD27/PLAUR/SPINK1,4
GO:0040014,GO:0040014,regulation of multicellular organism growth,2/39,64/18800,0.0077951796341629,0.0345690755133104,0.0187818266244972,CSF1/GDF15,2
GO:0002260,GO:0002260,lymphocyte homeostasis,2/39,65/18800,0.0080321749173424,0.0348482002629382,0.0189334787174812,CD74/LGALS9,2
GO:0002901,GO:0002901,mature B cell apoptotic process,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,CD74,1
GO:0002905,GO:0002905,regulation of mature B cell apoptotic process,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,CD74,1
GO:0002906,GO:0002906,negative regulation of mature B cell apoptotic process,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,CD74,1
GO:0019344,GO:0019344,cysteine biosynthetic process,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,GGT1,1
GO:0019747,GO:0019747,regulation of isoprenoid metabolic process,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,NPC2,1
GO:0043316,GO:0043316,cytotoxic T cell degranulation,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,CEACAM1,1
GO:0071866,GO:0071866,negative regulation of apoptotic process in bone marrow cell,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,FGFR2,1
GO:0098904,GO:0098904,regulation of AV node cell action potential,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,CXADR,1
GO:1905232,GO:1905232,cellular response to L-glutamate,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,BAIAP2,1
GO:1905274,GO:1905274,regulation of modification of postsynaptic actin cytoskeleton,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,BAIAP2,1
GO:2000346,GO:2000346,negative regulation of hepatocyte proliferation,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,CEACAM1,1
GO:2000670,GO:2000670,positive regulation of dendritic cell apoptotic process,1/39,4/18800,0.0082727455581705,0.0348482002629382,0.0189334787174812,LGALS9,1
GO:0009615,GO:0009615,response to virus,4/39,392/18800,0.0086095892923419,0.0360253572020103,0.0195730433344454,BST2/CXCL9/LGALS9/NPC2,4
GO:0061180,GO:0061180,mammary gland epithelium development,2/39,68/18800,0.008762472169522,0.0363046088713764,0.0197247643845677,CSF1/FGFR2,2
GO:0042180,GO:0042180,cellular ketone metabolic process,3/39,211/18800,0.0094636027725151,0.0390263058259094,0.0212034976039383,CD74/CEACAM1/COQ7,3
GO:0022412,GO:0022412,cellular process involved in reproduction in multicellular organism,4/39,406/18800,0.0097094579017451,0.0399468372880656,0.0217036342742972,CXADR/INHBB/NECTIN2/SPINK1,4
GO:0006196,GO:0006196,AMP catabolic process,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,NT5E,1
GO:0019064,GO:0019064,fusion of virus membrane with host plasma membrane,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,NECTIN2,1
GO:0031179,GO:0031179,peptide modification,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,GGT1,1
GO:0039663,GO:0039663,membrane fusion involved in viral entry into host cell,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,NECTIN2,1
GO:0060501,GO:0060501,positive regulation of epithelial cell proliferation involved in lung morphogenesis,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,FGFR2,1
GO:0060664,GO:0060664,epithelial cell proliferation involved in salivary gland morphogenesis,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,FGFR2,1
GO:0060916,GO:0060916,mesenchymal cell proliferation involved in lung development,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,FGFR2,1
GO:1902339,GO:1902339,positive regulation of apoptotic process involved in morphogenesis,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,TNFRSF1A,1
GO:1904016,GO:1904016,response to Thyroglobulin triiodothyronine,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,INHBB,1
GO:1990834,GO:1990834,response to odorant,1/39,5/18800,0.0103304899145883,0.0401930841764601,0.0218374233992874,IL4R,1
GO:0032418,GO:0032418,lysosome localization,2/39,79/18800,0.0116828384912728,0.0443364917300957,0.0240885904077037,IL4R/LGALS9,2
GO:1990849,GO:1990849,vacuolar localization,2/39,79/18800,0.0116828384912728,0.0443364917300957,0.0240885904077037,IL4R/LGALS9,2
GO:0048608,GO:0048608,reproductive structure development,4/39,433/18800,0.0120820761818926,0.0443364917300957,0.0240885904077037,FGFR2/GFRA1/INHBB/MME,4
GO:0061458,GO:0061458,reproductive system development,4/39,436/18800,0.0123667592700129,0.0443364917300957,0.0240885904077037,FGFR2/GFRA1/INHBB/MME,4
GO:0002023,GO:0002023,reduction of food intake in response to dietary excess,1/39,6/18800,0.0123840738940154,0.0443364917300957,0.0240885904077037,GDF15,1
GO:0008354,GO:0008354,germ cell migration,1/39,6/18800,0.0123840738940154,0.0443364917300957,0.0240885904077037,CXADR,1
GO:0071839,GO:0071839,apoptotic process in bone marrow cell,1/39,6/18800,0.0123840738940154,0.0443364917300957,0.0240885904077037,FGFR2,1
GO:0071864,GO:0071864,positive regulation of cell proliferation in bone marrow,1/39,6/18800,0.0123840738940154,0.0443364917300957,0.0240885904077037,FGFR2,1
GO:1900425,GO:1900425,negative regulation of defense response to bacterium,1/39,6/18800,0.0123840738940154,0.0443364917300957,0.0240885904077037,HAVCR2,1
GO:0031667,GO:0031667,response to nutrient levels,4/39,446/18800,0.0133468845241326,0.0474944580344637,0.0258043544174125,DSC2/GDF15/INHBB/SPINK1,4
GO:0051090,GO:0051090,regulation of DNA-binding transcription factor activity,4/39,452/18800,0.0139582398878053,0.0488029454743821,0.0265152725970849,HAVCR2/IL18R1/LGALS9/TNFRSF4,4
GO:0002606,GO:0002606,positive regulation of dendritic cell antigen processing and presentation,1/39,7/18800,0.014433505687041,0.0488029454743821,0.0265152725970849,CD74,1
GO:0017085,GO:0017085,response to insecticide,1/39,7/18800,0.014433505687041,0.0488029454743821,0.0265152725970849,INHBB,1
GO:0031394,GO:0031394,positive regulation of prostaglandin biosynthetic process,1/39,7/18800,0.014433505687041,0.0488029454743821,0.0265152725970849,CD74,1
GO:0035726,GO:0035726,common myeloid progenitor cell proliferation,1/39,7/18800,0.014433505687041,0.0488029454743821,0.0265152725970849,CEACAM1,1
GO:0046836,GO:0046836,glycolipid transport,1/39,7/18800,0.014433505687041,0.0488029454743821,0.0265152725970849,NPC2,1
GO:0060449,GO:0060449,bud elongation involved in lung branching,1/39,7/18800,0.014433505687041,0.0488029454743821,0.0265152725970849,FGFR2,1
GO:0061518,GO:0061518,microglial cell proliferation,1/39,7/18800,0.014433505687041,0.0488029454743821,0.0265152725970849,CSF1,1
